Search

Your search keyword '"Luc Dupuis"' showing total 75 results

Search Constraints

Start Over You searched for: Author "Luc Dupuis" Remove constraint Author: "Luc Dupuis" Topic medicine.disease Remove constraint Topic: medicine.disease
75 results on '"Luc Dupuis"'

Search Results

1. Disruption of orbitofrontal-hypothalamic projections in a murine ALS model and in human patients

2. Loss of nucleoporin Nup50 is a risk factor for amyotrophic lateral sclerosis

3. Morphological MRI investigations of the hypothalamus in 232 individuals with Parkinson's disease

4. Atxn2-CAG100-KnockIn mouse spinal cord shows progressive TDP43 pathology associated with cholesterol biosynthesis suppression

5. Synaptic FUS accumulation triggers early misregulation of synaptic RNAs in a mouse model of ALS

6. Dysregulation of energy homeostasis in amyotrophic lateral sclerosis

7. Serotonin and the 5-HT2B Receptor in Amyotrophic Lateral Sclerosis

8. Hypothalamus and weight loss in amyotrophic lateral sclerosis

9. Wild-type FUS corrects ALS-like disease induced by cytoplasmic mutant FUS through autoregulation

10. Orbitofrontal-hypothalamic projections are disrupted in hypermetabolic murine ALS model and human patients

11. Effect of high-caloric nutrition on serum neurofilament light chain levels in amyotrophic lateral sclerosis

12. Synaptic accumulation of FUS triggers age-dependent misregulation of inhibitory synapses in ALS-FUS mice

13. Association of Insulin-like Growth Factor 1 Concentrations with Risk for and Prognosis of Amyotrophic Lateral Sclerosis - Results from the ALS Registry Swabia

14. Multiplexed chemogenetics in astrocytes and motoneurons restore blood–spinal cord barrier in ALS

15. Could Conservative Iron Chelation Lead to Neuroprotection in Amyotrophic Lateral Sclerosis?© Caroline Moreau et al. 2018; Published by Mary Ann Liebert, Inc. This Open Access article distributed under the terms of the Creative Commons License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited

16. Safety and efficacy of rasagiline as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomised, double-blind, parallel-group, placebo-controlled, phase 2 trial

17. Reversible induction of TDP-43 granules in cortical neurons after traumatic injury

18. Degeneration of serotonin neurons triggers spasticity in amyotrophic lateral sclerosis

19. Hypothalamic atrophy is related to body mass index and age at onset in amyotrophic lateral sclerosis

20. FUS-mediated regulation of acetylcholine receptor transcription at neuromuscular junctions is compromised in amyotrophic lateral sclerosis

21. Paradox of amyotrophic lateral sclerosis and energy metabolism

22. Association of Serum Retinol-Binding Protein 4 Concentration With Risk for and Prognosis of Amyotrophic Lateral Sclerosis

23. Thermoregulation in amyotrophic lateral sclerosis

24. Hypertonic Stress Causes Cytoplasmic Translocation of Neuronal, but Not Astrocytic, FUS due to Impaired Transportin Function

25. The dark side of HDAC inhibition in ALS

26. Percutaneous endoscopic gastrostomy in amyotrophic lateral sclerosis: a prospective observational study

27. Low dietary protein content alleviates motor symptoms in mice with mutant dynactin/dynein-mediated neurodegeneration

28. Life course body mass index and risk and prognosis of amyotrophic lateral sclerosis: results from the ALS registry Swabia

29. Hypothalamic Alterations in Neurodegenerative Diseases and Their Relation to Abnormal Energy Metabolism

30. ALS-causing mutations differentially affect PGC-1α expression and function in the brain vs. peripheral tissues

31. Body fat distribution in Parkinson's disease: An MRI-based body fat quantification study

32. Mechanisms, models and biomarkers in amyotrophic lateral sclerosis

33. Degeneration of serotonergic neurons in amyotrophic lateral sclerosis: a link to spasticity

34. Investigating the contribution of VAPB/ALS8 loss of function in amyotrophic lateral sclerosis

35. Toxic gain of function from mutant FUS protein is crucial to trigger cell autonomous motor neuron loss

36. Serotonin 2B receptor slows disease progression and prevents degeneration of spinal cord mononuclear phagocytes in amyotrophic lateral sclerosis

37. BBS-Induced Ciliary Defect Enhances Adipogenesis, Causing Paradoxical Higher-Insulin Sensitivity, Glucose Usage, and Decreased Inflammatory Response

38. Energy metabolism in amyotrophic lateral sclerosis

39. Oxidative stress in skeletal muscle stimulates early expression of Rad in a mouse model of amyotrophic lateral sclerosis

40. P-glycoprotein expression and function are increased in an animal model of amyotrophic lateral sclerosis

41. Impaired glucose tolerance in patients with amyotrophic lateral sclerosis

42. Mice with a mutation in the dynein heavy chain 1 gene display sensory neuropathy but lack motor neuron disease

43. Muscle Nogo-a expression is a prognostic marker in lower motor neuron syndromes

44. Amyotrophic lateral sclerosis: all roads lead to Rome

45. Adipose Tissue Distribution in Patients with Alzheimer's Disease: A Whole Body MRI Case-Control Study

46. Nogo expression in muscle correlates with amyotrophic lateral sclerosis severity

47. Early Activation of Antioxidant Mechanisms in Muscle of Mutant Cu/Zn-Superoxide Dismutase-Linked Amyotrophic Lateral Sclerosis Mice

48. Neuroendocrinology of Neurodegenerative Diseases

49. Denervation Is Not a Primary Cause of Prion Protein Down-Regulation Occurring in the Spinal Cord of a Transgenic Model of Amyotrophic Lateral Sclerosis

50. Nogo Provides a Molecular Marker for Diagnosis of Amyotrophic Lateral Sclerosis

Catalog

Books, media, physical & digital resources